Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Dermatol Online J ; 17(4): 11, 2011 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-21549086

RESUMEN

Leukemia cutis is defined as a skin infiltration by leukemic cells. The diagnosis of myeloid leukemia cutis (MLC) can represent a challenge, especially in those cases without symptoms of systemic disease. The clinical appearance, histopathological analysis and immunohistochemical profile can be indistinguishable from those observed in cases of hystiocitoid Sweet syndrome (HSS). We present a case of MLC in which the cutaneous affectation was the first sign of the systemic leukemia. In this setting, the myeloperoxidase stain was the clue to rule out the possibility of HSS. We discuss the role and the utility of the myeloperoxidase stain in the differentiation of these two entities.


Asunto(s)
Biomarcadores de Tumor/análisis , Leucemia Mieloide Aguda/diagnóstico , Infiltración Leucémica/diagnóstico , Peroxidasa/análisis , Neoplasias Cutáneas/diagnóstico , Piel/patología , Síndrome de Sweet/diagnóstico , Anciano , Antineoplásicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Citarabina/uso terapéutico , Diagnóstico Diferencial , Humanos , Idarrubicina/uso terapéutico , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/enzimología , Infiltración Leucémica/enzimología , Masculino , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/enzimología , Coloración y Etiquetado/métodos , Síndrome de Sweet/enzimología , Resultado del Tratamiento
2.
J Dermatolog Treat ; 28(5): 401-405, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28001499

RESUMEN

BACKGROUND: Methotrexate (MTX), a traditional antipsoriatic drug, is very frequently used either as monotherapy or in combination with other systemic drugs. OBJECTIVES: To assess the effectiveness and safety of MTX in psoriasis in usual clinical practice. METHODS: We conducted a retrospective study. We performed an electronic and manual chart review of patients treated with MTX in the Psoriasis Unit of our Hospital from January 2007 to December 2014. Demographic and clinical data, PASI/DLQI scores and reasons for suspension of all patients treated with MTX in usual clinical practice were recorded. RESULTS: Two hundred and eighteen patients were included. MTX was administered in 67% of cases as the first systemic treatment. The average treatment duration was 17.2 ± 13.6 months. All patients were subjected to clinical and laboratory monitoring. About 33.5% of them achieved a reduction of 75% or more of the initial PASI at week 12, 34.9% at week16, 44.7% at week 24, and 52.8% at week 48. A 3.3% had to discontinue the therapy due to analytical hepatic (2.8%) or renal (0.5%) abnormalities. Only one patient experienced severe interstitial pneumonitis and none required liver biopsy. CONCLUSIONS: MTX is an effective and safe option for the treatment of psoriasis in the real-world clinical practice.


Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Metotrexato/uso terapéutico , Psoriasis/tratamiento farmacológico , Adulto , Anciano , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Fármacos Dermatológicos/efectos adversos , Femenino , Humanos , Enfermedades Renales/etiología , Masculino , Metotrexato/efectos adversos , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento
4.
Int J Dermatol ; 51(2): 216-20, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22250634

RESUMEN

Folliculitis decalvans is an embarrassing and challenging disease with no established treatment guidelines. In this paper, we described four patients with this disease treated successfully with Tacrolimus ointment. All of them showed significant control of the condition, stopping inflammatory lesions and progression of the disease, although weak transitory outbreaks of inflammatory lesions were observed in some cases. Alopecia and tufted hairs remained unchanged. The discontinuation of the therapy produced rapid relapses in all cases. Close monitoring of these patients is recommended due to the potential risk of malignant transformation of the disease.


Asunto(s)
Foliculitis/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Tacrolimus/uso terapéutico , Adulto , Femenino , Foliculitis/patología , Humanos , Masculino , Pomadas , Dermatosis del Cuero Cabelludo/patología , Resultado del Tratamiento , Adulto Joven
5.
Ann Dermatol ; 23(Suppl 3): S364-7, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22346279

RESUMEN

A 77-year-old woman presented with a trauma to the scalp caused from the blade of a windmill. The condition was persistent from the past 50 years. At the initial examination, a deep, foul-smelling and well-circumscribed ulcer was apparent on the head region, involving the majority of the cranium. Skin biopsy specimens of the lesion were nonspecific. The bone biopsy showed extensive necrotic areas of bone and soft tissues, with lymphocytic exudate foci. A computed tomography scan of the head revealed bone destruction principally involving both the parietal bones, and parts of the frontal and occipital bones. Streptococcus parasanguis was isolated from the skin culture, and Proteus mirabilis and Peptostreptococcus sp. were identified in the cultures from the bone. A long-term treatment with amoxicillin-clavulanic acid (1 g/12 h) and levofloxacin (500 mg/day) was prescribed, but even after 6 months, the lesion remained unchanged. The frequency of occurrence of scalp ulcers in dermatological patients is less, principally because of the rich blood supply to this area. We have not found any similar case report of a scalp ulcer secondary to chronic osteomyelitis discovered more than 50 years after the causal trauma. We want to highlight the importance of complete cutaneous evaluation including skin and bone biopsies, when scalp osteomyelitis is suspected.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA